Methods for enabling pet ownership
The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.
1. A method of enabling an individual having a cat allergy to have a specific cat as a pet, the method comprising:
using a primary fan and a secondary fan to suspend and/or distribute a FelD1 allergen aerosolized by the specific cat, wherein the primary fan directs air in a first direction at and/or across an allergen source comprising the FelD1 allergen, and the secondary fan directs air at and/or across the allergen source in at least a second direction opposite to the first direction, to produce air turbulence adjacent to and/or above the allergen source such that the air turbulence maintains particles from the allergen source in suspension;
measuring an amount of the FelD1 allergen aerosolized by the specific cat; and
selecting the specific cat as a pet for the individual if the amount of FelD1 aerosolized by the specific cat is less than an amount of FelD1 which induces allergic symptoms in the individual.
2. The method of claim 1 , further comprising identifying one or more portions of the year having a higher expression of FelD1 allergen relative to at least one other portion of the year, and subsequently the measuring of the amount of the FelD1 allergen aerosolized by the specific cat is performed in at least one of the one or more portions of the year having a higher expression of FelD1 allergen.
3. The method of claim 1 , further comprising quantitatively determining the amount of FelD1 which induces allergic symptoms in the individual by (i) measuring a quantity of the FelD1 in cat hair from a different cat, (ii) positioning the cat hair in a chamber, (iii) distributing the quantity of the FelD1 from the cat hair in the chamber, (iv) having the individual in the chamber, and (v) measuring the allergic symptoms of the individual.
4. The method of claim 3 , wherein the individual is symptomatic from the quantity of the FelD1 distributed from the cat hair in the chamber, thereby identifying the amount of FelD1 which induces allergic symptoms in the individual.
5. The method of claim 1 , wherein the suspending and/or distributing of the FelD1 allergen is performed for a predetermined time period.
6. The method of claim 1 , wherein the allergen source is selected from the group consisting of an open container in which cat hair from the specific cat is positioned and a litter box containing litter soiled by the specific cat.